Madrigal Pharmaceuticals MDGL
NASDAQ MDGL
$499.40 -0.31 (-0.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Madrigal Pharmaceuticals (MDGL) Selling, General & Administrative (2010 - 2026)

Updated

Madrigal Pharmaceuticals' Selling, General & Administrative was $289.38 million in Q2 2026, up 47.0% from $196.86 million a year earlier and up 7.8% from the prior quarter.

Analysis

Madrigal Pharmaceuticals (MDGL) Selling, General & Administrative (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Madrigal Pharmaceuticals' Selling, General & Administrative was $1.01 billion through Jun 30, 2026, up 64.1% year-over-year; for FY2025, it came in at $813.83 million, up 87.1% from FY2024.

  • Selling, General & Administrative has now increased for five consecutive years, with a five-year compound annual growth rate of 106.1% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $435.06 million in FY2024 (+302.3%), $108.15 million in FY2023 (+124.7%), $48.13 million in FY2022 (+29.0%) and $37.32 million in FY2021 (+70.7%).
  • The Q2 2026 figure marks the highest quarterly Selling, General & Administrative in data going back to Q2 2010.
  • Compared with a year earlier, Selling, General & Administrative has increased for 24 straight quarters, with growth averaging 119.9% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Selling, General & Administrative ranged from 16.5% (Q2 2022) to 490.9% (Q2 2024).
  • Per Business Quant data, MDGL's Selling, General & Administrative in the three quarters before Q2 2026 was $268.52 million (Q1 2026), $239.98 million (Q4 2025) and $209.12 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Madrigal Pharmaceuticals 14.56 Bn 10.82 Bn - 289.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 289.38 Mn
Mar 31, 2026 268.52 Mn
Dec 31, 2025 239.98 Mn
Sep 30, 2025 209.12 Mn
Jun 30, 2025 196.86 Mn
Mar 31, 2025 167.88 Mn
Dec 31, 2024 141.22 Mn
Sep 30, 2024 107.59 Mn
Jun 30, 2024 105.45 Mn
Mar 31, 2024 80.80 Mn
Dec 31, 2023 46.54 Mn
Sep 30, 2023 27.58 Mn
Jun 30, 2023 17.85 Mn
Mar 31, 2023 16.18 Mn
Dec 31, 2022 14.56 Mn
Sep 30, 2022 12.14 Mn
Jun 30, 2022 11.77 Mn
Mar 31, 2022 9.66 Mn
Dec 31, 2021 11.71 Mn
Sep 30, 2021 8.29 Mn
API Access

Madrigal Pharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=MDGL&period=max&api_key=YOUR_API_KEY